Chris Teleha joins MercachemSyncom

MercachemSyncom, the leading mid-sized European drug-discovery contract research organization (CRO) offering drug-discovery research and development services, is pleased to announce that Dr. Chris Teleha has taken a new role as VP Business Development CMC US at MercachemSyncom, starting September 1, 2020.

Click here to read the full press release

Scroll to top